Navigation Links
Among Newly Diagnosed Type 2 Diabetes Patients, DPP-IV Inhibitors are the Leading Oral Therapies After Standard Metformin and Sulfonylurea
Date:10/2/2013

BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl peptidase (DPP-IV) inhibitors claim the largest share among branded oral therapies of newly diagnosed type 2 diabetes patients across all three lines of therapy. DPP-IV inhibitors include Merck's Januvia, Bristol-Myers Squibb/AstraZeneca's Onglyza and Boehringer Ingelheim's Tradjenta. According to Treatment Algorithms in Type 2 Diabetes, metformin and sulfonylureas continue to dominate first-line therapy use, while long-acting insulins are also more heavily used as a first-line therapy than the DPP-IV inhibitors, despite ADA/EASD guidelines recommending oral antidiabetic therapy prior to insulin administration.

The report also examines recently treated type 2 diabetes patients. This group represents patients treated in the first quarter of 2013 and reviews retrospective analysis of the preceding two years of therapy. The year-over-year trend analysis found that among recently treated patients use of rapid- and long-acting insulins continue to gain patient share, while DPP-IV inhibitors and GLP-1 receptor agonists' patient share also steadily grow, which is likely to be at the expense of the PPAR-gamma agonists.

"The increased use of long-acting insulins such as Sanofi's Lantus as a first line treatment may indicate that physicians are implementing more aggressive initial therapy than suggested in the treatment guidelines in an attempt to improve glycemic control," said Decision Resources Analyst Eamonn O'Connor, Ph.D. "However, the increased use of rapid-acting insulins would indicate that current long-acting insulins are failing to provide complete 24-hour glycem
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dr. Prem Reddy Named Among Most Influential Physician Executives in Nation
2. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
3. Imaging Healthcare Specialists Among the First in the Nation to Offer Imaging Diagnosis for Alzheimers Disease
4. Advanced Radiology Among the First in the U.S. to Offer New Alzheimers Disease Tracer
5. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
6. Frost & Sullivan: Miniaturization of Medical Devices Reduces Mortality Rates among Cardiac Dysrhythmia Patients
7. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
8. CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Ski
9. Forbes Ranks SynCardia Among "Americas Most Promising Companies" for Second Straight Year
10. GNC NutriWater, COTYs Beyonce Pulse NYC, Swansons Super DPA Fish Oil, Among First SupplySide Insights Awards Finalists
11. Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 The March 3, 2015, order from ... must change their products, labels to clarify the drugs, intended ... and stroke is necessary to protect the public from injury ... partner at Simmons Hanly Conroy . The ... that the products – currently taken by millions of U.S. ...
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... , May 10 /PRNewswire-Asia/ -- On April ... cases with Beijing Un-Assegai Technical &,Trade Co. Ltd. (hereinafter referred ... China , as claimant and U.S. Abbott,Laboratories (Abbott U.S.; ... by the,China International Economic and Trade Arbitration Commission (CIETAC), which,has ...
... , Fla., May 10 Dr. Richard ... with newly diagnosed type 1 diabetes for Protege Encore, a ... of two Phase III studies testing the safety and efficacy ... as Protege, has completed enrollment of more than 530 subjects ...
Cached Medicine Technology:Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:3/5/2015)... Obesity can cause the human body to ... drinks each day can help promote weight loss in ... advocate Sharon Kleyne and sports doctor Robert Weil, during ... of Water® radio show. , Weil is a ... and sports medicine. His weekly radio show, "The ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Hope For The ... Sporting Clay Shoot to be held at Beretta Shooting Grounds ... 2015. All proceeds from the event will benefit Hope For ... of self, restoring the family unit, and restoring hope for ... will honor our nation’s heroes through a day of clay ...
(Date:3/5/2015)... LOUISIANA (PRWEB) March 05, 2015 ... its continued support of the annual American Heart Association’s ... year, Bret Kolman, Lakeview Regional Chief Executive Officer, is ... place on Saturday, March 21, 2015 at Fontainebleau State ... sponsorship, Lakeview Regional has 20 individual teams participating in ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... Professor of Psychiatry and Psychology Department of Neuroscience, ... at the upcoming BioConference Live Neuroscience, a two-day ... , The webcast , titled “Dopamine System ... is scheduled for Thursday, March 18, from 9 ...
(Date:3/5/2015)... San Diego, CA (PRWEB) March 05, 2015 ... of the groundbreaking for Cielo Carmel on March 4 ... court will feature speakers: Sherri Lightner, Council president, ... Affirmed Housing; Charmaine Atherton, Senior Vice President, Southern ... Richard Gentry, President & CEO, San Diego Housing Commission. ...
Breaking Medicine News(10 mins):Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 3Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 3Health News:SD City Council President Sherri Lightner and Affirmed Housing Break Ground on Affordable Homes in Carmel Valley 2
... CLARA, Calif., Dec. 3 Coherent, Inc.,(Nasdaq: COHR ... received the,decision of the Board of Directors of The ... 2007 to file its past due periodic reports,for the ... quarterly periods,of 2007 with the Securities Exchange Commission ("SEC") ...
... Mass., Dec. 3 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... the annual American Society of Hematology (ASH) meeting ... visiting the Investors section of the,Company,s website, ... The presentation will be delivered by Millennium ...
... first survey to specifically measure hospital pediatric preparedness, a ... researchers found few U.S. emergency rooms are properly equipped ... Charles Schmitz and Roger J. Lewis was reported in ... the American Academy of Pediatrics. The team of LA ...
... care and lack of transportation combine to limit access, CDC ... Almost 20 percent of Americans, or more than 40 million ... a new U.S. government report released Monday. , Access to ... United States, 2007 report from the Centers for Disease ...
... Vegas and Tucson Marathon Runners, PLEASANT GROVE, Utah, ... to prevent inflammation and pain, but at the same ... at,Appalachian State University and Vanderbilt University, published in,Medicine & ... exercise may be unhealthy in the long term. The ...
... Front Needs of Families with Deployed Service Members ... ... will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief Fund, ... their families., Don Brown, market vice president for the central market area ...
Cached Medicine News:Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event 2Health News:LA BioMed researchers find few emergency rooms fully equipped for pediatric patients 2Health News:Almost 1 in 5 Americans Going Without Health Care 2Health News:Almost 1 in 5 Americans Going Without Health Care 3Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2
... enables highly sensitive time-resolved fluorescence detection ... fluorophores. These compounds are excited with ... fluorescence lifetimes (several hundred microseconds), large ... profiles at 620 nm. Therefore with ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
Medicine Products: